Sex hormone concentrations and the risk of breast cancer recurrence in postmenopausal women without hot flashes

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 5, 2011, Pages 939-945

  Emond, Jennifer A ^a,c   Patterson, Ruth E ^a,b   Natarajan, Loki ^a,b   Laughlin, Gail A ^b   Gold, Ellen B ^d   Pierce, John P ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; BIOLOGICAL MARKER; ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TAMOXIFEN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; BODY MASS; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DIET THERAPY; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; FEMALE; HAZARD RATIO; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; RISK ASSESSMENT; RISK REDUCTION; SELF REPORT; TESTOSTERONE BLOOD LEVEL; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HOT FLASHES; HUMANS; INTERVENTION STUDIES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; YOUNG ADULT;

EID: 79955783992     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-1240     Document Type: Article

References (26)

1. Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER, Flatt SW, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 2007;298:289-98. (Pubitemid 47080483)
2. Gold EB, Pierce JP, Natarajan L, Stefanick ML, Laughlin GA, Caan BJ, et al. Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial. J Clin Oncol 2009;27:352-9.
3. Avis NE, Crawford S, McKinlay SM. Psychosocial, behavioral and health factors related to menopause symptomatology. Womens Health 1997;3:103-20.
4. Erlik Y, Meldrum DR, Judd HL. Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol 1982;59:403-7. (Pubitemid 12137195)
5. Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL. Pathophysiology and treatment of hot flashes. Mayo Clin Proc 2002;77:1207-18. (Pubitemid 35266369)
6. Freedman RR, Subramanian M. Effects of symptomatic status and the menstrual cycle on hot flash-related thermoregulatory parameters. Menopause 2005;12:156-9. (Pubitemid 40464283)
7. Wu AH, Pike MC, Stram DO. Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 1999;91:529-34. (Pubitemid 29157061)
8. Rose DP, Connolly JM, Chlebowski RT, Buzzard IM, Wynder EL. The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Res Treat 1993;27:253-62. (Pubitemid 23355312)
9. Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006;295:629-42. (Pubitemid 43209065)
10. Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of osteoporotic fractures research group. Ann Intern Med 1999;130:270-7. (Pubitemid 29091854)
11. Rock CL, Flatt SW, Laughlin GA, Gold EB, Thomson CA, Natarajan L, et al. Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev 2008;17:614-20. (Pubitemid 351469211)
12. Sodergard R, Backstrom T, Shanbhag V, Cartensen H. Calculation of free and bound fractions of testosterone and estradiol-17b to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801-10. (Pubitemid 13228095)
13. Rock CL, Flatt SW, Thomson CA, Stefanick ML, Newman VA, Jones LA, et al. Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer. J Clin Oncol 2004;22:2379-87. (Pubitemid 41115395)
14. Berrino F, Pasanisi P, Bellati C, Venturelli E, Krogh V, Mastroianni A, et al. Serum testosterone levels and breast cancer recurrence. Int J Cancer 2005;113:499-502. (Pubitemid 40038721)
15. Micheli A, Meneghini E, Secreto G, Berrino F, Venturelli E, Cavalleri A, et al. Plasma testosterone and prognosis of postmenopausal breast cancer patients. J Clin Oncol 2007;19:2685-90. (Pubitemid 47123174)
16. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schunemann HJ, et al. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002;11:1361-8. (Pubitemid 35340370)
17. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002;20:42-51. (Pubitemid 34032594)
18. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009;101:48-60.
19. Maturana MA, Breda V, Lhullier F, Spritzer PM. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism 2008;57:961-5. (Pubitemid 351814689)
20. Golden SH, Dobs AS, Vaidya D, Szklo M, Gapstur S, Kopp P, et al. Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab 2007;92:1289-95. (Pubitemid 46556400)
21. Patel SM, Ratcliffe SJ, Reilly MP, Weinstein R, Bhasin S, Blackman MR, et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2009;94:4776-84.
22. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 2002;25:55-60. (Pubitemid 41070783)
23. Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI. Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab 2003;88:1646-52. (Pubitemid 36623382)
24. Berrino F, Bellati C, Secreto G, Camerini E, Pala V, Panico S, et al. Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev 2001;10:25-33. (Pubitemid 32106041)
25. Cauley JA, Gutai JP, Kuller LH, Powell JG. Reliability and interrelations among serum sex hormones in postmenopausal women. Am J Epidemiol 1991;133:50-57.
26. Goetz MP, Rae JM, Suman VJ, Safgren SL, Ames MM, Visscher DW, et al. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol 2005;23:9312-8.